Incorporating Human Factors into the development process for connected drug-delivery systems

Many companies believe that by combining their medical devices or drug-delivery systems with connected capabilities, they can boost patient compliance and learn more about the products they have on the market. But developing a connected drug-delivery system comes with a unique set of challenges*. One of those challenges is incorporating Human Factors into the development process for connected drug delivery systems to achieve both commercial goals and meet regulatory requirements.

 

At the interactive workshop during SMi’s Pre-Filled Syringes East Coast Conference (11 – 12 April, Boston, MA, USA) representatives of CAMBRIDGE CONSULTANTS, Melanie Turieo, Director, Human Factors Engineering and Karen Unterman, Group Leader, Human Factors Engineering will help you to identify the considerations that need to be addressed when designing a comprehensive Human Factors engineering process for a system which contains both physical and digital elements. The workshop will take place on April 10th at the Sheraton Boston Hotel.

 

View more detailed information about this workshop on the website  http://www.pfsamericas.com/pharmaphorum

 

Pre-Filled Syringes East Coast Conference (11 – 12th April) will feature exclusive operational case studies and keynote addresses from medical device experts and market specialists, allowing you to expand your horizons into the next generation of pre-filled syringes and combination drug product

 

Check out the agenda of Pre-Filled Syringes East Coast Conference at http://www.pfsamericas.com/pharmaphorum

 

LinkedIn – search ‘SMi Pharma’

Twitter – we are @SMIpharm and #smipfsusa

 

————————————————————————————————–

Pre-Filled Syringes East Coast | April 11th – 12th 2018 | Boston, USA

 

Relevant event:

Pre-Filled Syringes West Coast Conference | 4 – 5th June 2018 | Mission Valley, CA, United States

http://www.prefilled-syringes-westcoast.com/pharmaphorum

————————————————————————————————–
*drugdeliverybusiness, DECEMBER 19, 2017 BY SARAH FAULKNER